Abstract
Orally disintegrating tablets (ODTs) have emerged as a preferred dosage form due to their ability to rapidly dissolve or disintegrate in the mouth without the need for water. This property enhances patient compliance, especially for those with swallowing difficulties, such as pediatric, geriatric, or dysphagic patients. However, the formulation of ODTs presents several challenges, including ensuring rapid disintegration, maintaining stability, achieving appropriate taste masking, and managing the delicate balance between excipients and active pharmaceutical ingredients. This article discusses the various hurdles encountered during the formulation of ODTs and explores strategies to overcome them, focusing on the formulation components, manufacturing processes, and clinical considerations.

This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2022 Dr. John Doe (Author)